Download your free eBook: Accelerating Dengue research with the highest quality proteins and antibodies
The dengue virus poses a significant risk to global health and there is currently no vaccine or specific treatment available for those infected.
A major challenge faced by academic researchers, drug developers and public health scientists is Dengue’s close structural similarity to the Zika virus – which continues to hamper research efforts, requiring more sensitive diagnostic tools to differentiate between them.
In this eBook, we discuss:
- The challenges to preventing the proliferation of DENV across the globe.
- The key DENV proteins used in the research and development of vaccines, diagnostics and therapeutics.
- Overcoming some of the major challenges in DENV research.
- The advantages of using the highest quality recombinant DENV proteins and antibodies.
Simply fill out the form below to get your copy.